Fresenius Kabi USA‘s patent involves a method where a second fluid delivery device is associated with a first device in a medical environment via wireless communication. This allows for better management of fluid delivery systems by caregivers, enabling efficient transmission of medical information between devices. GlobalData’s report on Fresenius Kabi USA gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights Fresenius Kabi USA LLC - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Fresenius Kabi USA, was a key innovation area identified from patents. Fresenius Kabi USA's grant share as of February 2024 was 65%. Grant share is based on the ratio of number of grants to total number of patents.

Method for associating and managing multiple fluid delivery devices

Source: United States Patent and Trademark Office (USPTO). Credit: Fresenius Kabi USA LLC

A recently granted patent (Publication Number: US11857755B2) outlines a method that involves receiving input over a network to associate a second fluid delivery device with a first fluid delivery device in a medical environment. The association allows both devices to be used by a caregiver to deliver fluids to a recipient. The method includes transmitting medical information from the first device to the second device, displaying this information on the second device's screen, and enabling the caregiver to initiate delivery of a second fluid. The patent also covers generating warnings based on fluid volume infused, displaying patient information, and assigning devices to recipients and caregivers based on associations.

Furthermore, the patent details a process where a wireless message is sent from the first fluid delivery device to invite the second device to join a group, with the second device displaying a visual prompt upon receiving the invitation. The caregiver can then accept the invitation, leading to an association between the devices for fluid delivery. The method includes controlling fluid delivery, displaying notifications of device group inclusion, and showcasing attributes of delivered fluids on the second device's screen. The patent emphasizes the role of wireless communication, caregiver input, and device associations in facilitating efficient and coordinated fluid delivery in medical settings.

To know more about GlobalData’s detailed insights on Fresenius Kabi USA, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies